基于iPSC的细胞替代疗法:从基础研究到临床应用
1Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Cytotherapy
|February 19, 2025
概括
诱导多能干细胞 (iPSCs) 正在推动帕金森病的再生医学. 来自iPSC的神经元显示出细胞替代疗法的前景,临床试验即将到来.
科学领域:
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
- 神经科学是一个神经科学.
背景情况:
- 诱导多能干细胞 (iPSC) 技术对再生医学产生了重大影响,为疾病建模,药物发现和细胞替代疗法提供了新的途径.
- 细胞替代疗法,特别是使用iPSC衍生细胞,是治疗退行性疾病的关键重点.
- 替代效应机制对于实现长期组织再生和功能恢复至关重要.
研究的目的:
- 审查基于iPSC的再生医学的进展,特别强调细胞替代疗法.
- 探索iPSC技术在帕金森病中的应用,包括诱导多巴胺基神经元.
- 突出跨学科合作对于iPSC疗法的成功临床转化的重要性.
主要方法:
- 审查关于iPSC技术及其在再生医学中的应用现有的文献.
- 专注于研究详细介绍从iPSCs诱导中脑多巴胺基神经元的研究.
- 动物研究分析表明iPSC衍生细胞的安全性和整合性.
主要成果:
- iPSC技术在疾病建模和药物发现方面取得了重大进展.
- 从iPSCs中成功诱导中脑多巴胺基神经元已经实现,精确的信号传递对安全性和有效性至关重要.
- 动物研究证实了这些细胞的整合和安全性,支持进入临床试验的进展.
结论:
- 基于iPSC的细胞替代疗法对治疗像帕金森氏症这样的神经退行性疾病有很大的前景.
- 监管机构,研究人员,临床医生和行业之间的战略合作对于临床成功至关重要.
- 预计iPSC技术的持续进步将扩大治疗应用,并改善患者的治疗结果.
更多相关视频
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
7.1K
10:03Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
9.7K
相关概念视频
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:13Induced Pluripotent Stem Cells
21.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.8K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:17Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K